Tezosentan in Pulmonary Arterial Hypertension
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01077297 |
|
Recruitment Status :
Terminated
(Due to slow recruitment, the study was prematurely discontinued)
First Posted : March 1, 2010
Last Update Posted : July 9, 2018
|
Sponsor:
Idorsia Pharmaceuticals Ltd.
Information provided by (Responsible Party):
Idorsia Pharmaceuticals Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | November 2010 |
| Actual Study Completion Date : | September 2011 |
| Certification/Extension First Submitted : | July 13, 2012 |